SCHEMBL14030779

SCHEMBL14030779

CC(=O)OC[C@H]1O[C@@H](n2cnc3c(Cl)nc([N+](=O)[O-])nc32)C(OC(C)=O)[C@H]1OC(C)=O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.77
ALDH1A1 P00352 2/20 0.77
TP53 P04637 2/20 0.77
MAPT P10636 1/20 0.77
TDP1 Q9NUW8 1/20 0.77
ACHE P22303 5/20 0.49
PRKAB2 O43741 1/20 0.49
PRKAG1 P54619 1/20 0.49
PRKAA2 P54646 1/20 0.49
PRKAA1 Q13131 1/20 0.49
PRKAG3 Q9UGI9 1/20 0.49
PRKAG2 Q9UGJ0 1/20 0.49
PRKAB1 Q9Y478 1/20 0.49
ADORA3 P0DMS8 5/20 0.45
THRB P10828 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HIF1A Q16665 1/20 0.43
ADORA2A P29274 1/20 0.41
ADORA2B P29275 1/20 0.41
ADORA1 P30542 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14075779 1.00 LMNA (0.77) LMNAALDH1A1TP53MAPTTDP1
SCHEMBL14088747 1.00 LMNA (0.77) LMNAALDH1A1TP53MAPTTDP1
SCHEMBL13863575 0.87 ALDH1A1 (0.60) LMNAALDH1A1TP53MAPTTDP1
SCHEMBL13863562 0.87 ALDH1A1 (0.60) LMNAALDH1A1TP53MAPTTDP1
SCHEMBL24371902 0.87 LMNA (1.00) LMNAALDH1A1TP53MAPTTDP1
SCHEMBL5492975 0.87 ALDH1A1 (0.85) LMNAALDH1A1TP53MAPTTDP1
SCHEMBL22826797 0.87 LMNA (1.00) LMNAALDH1A1TP53MAPTTDP1
SCHEMBL21798516 0.87 LMNA (1.00) LMNAALDH1A1TP53MAPTTDP1
SCHEMBL13012214 0.87 LMNA (1.00) LMNAALDH1A1TP53MAPTTDP1
SCHEMBL3770300 0.87 LMNA (1.00) LMNAALDH1A1TP53MAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080262214-A1 Synthesis of 2-Substituted Adenosines CAMBRIDGE BIOTECHNOLOGY LIMITED (GB) 2008-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080262214-A1 Synthesis of 2-Substituted Adenosines ADORA3, ADORA1, ADORA2A LMNA 1170/4885ALDH1A1 839/4885TP53 4170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.